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This study examines the genetic inﬂuence of β-adrenergic receptor gene polymorphisms (β2-AR Arg16Gly and β3-AR Trp64Arg)
on the relationship of birthweight to longitudinal changes of blood pressure (BP) from childhood to adulthood in 224 black
and 515 white adults, aged 21–47 years, enrolled in the Bogalusa Heart Study. Blacks showed signiﬁcantly lower birthweight and
frequencies of β2-AR Gly16 and β3-AR Trp64 alleles and higher BP levels and age-related trends than whites. In multivariable
regression analyses using race-adjusted BP and birthweight, low birthweight was associated with greater increase in age-related
trend of systolic BP (standardized regression coeﬃcient β =− 0.09, P = .002) and diastolic BP (β =− 0.07, P = .037)
in the combined sample of blacks and whites, adjusting for the ﬁrst BP measurement in childhood, sex, age, and gestational
age. Adjustment for the current body mass index strengthened the birthweight-BP association. Importantly, the strength of the
association, measured as regression coeﬃcients, was modulated by the combination of β2-AR and β3-AR genotypes for systolic
(P = .042 for interaction) and diastolic BP age-related trend (P = .039 for interaction), with blacks and whites showing a similar
trend in the interaction. These ﬁndings indicate that the intrauterine programming of BP regulation later in life depends on β-AR
genotypes.
1.Introduction
Low birthweight is an indicator of intrauterine growth
retardation. The relationship between low birthweight and
elevated blood pressure (BP) levels later in life and the
mechanisms of fetal programming have been extensively
studied since the fetal origins hypothesis was proposed [1–
4]. However, evidence for the developmental programming
of adult hypertension thus far is still inconsistent, partic-
ularly in pediatric populations [5–7]. Recently, researchers
have outlined substantive challenges to the birthweight-
BP association. One of the criticisms is the inappropriate
use of statistical methodology and improper interpretation
of epidemiologic analyses in support of the fetal origins
hypothesis [3, 8–12].
β-adrenergic receptors (β-ARs) play a pivotal role in
regulation of cardiac, pulmonary, vascular, endocrine, and
sympathetic nervous systems [13, 14]. Three β-AR subtypes
(β1-AR, β2-AR, and β3-AR) are pharmaceutically charac-
terized [14, 15]. Polymorphisms of the β-AR genes have
been found to be associated with multiple cardiovascular
risk variables, including hemodynamic factors such as heart
rate, vasodilation, and BP [16]. Further, the β-AR genes are
associated with preterm birth and modulate the relationship
between birthweight and insulin resistance in later life [17–
20]. However, whether genetic variations in the β-AR genes
modulate the inﬂuence of birthweight on BP is not known,
especially for BP longitudinal changes.
As part of the Bogalusa Heart Study, a long-term biracial
(black-white) community-based epidemiologic study of the
early natural history of cardiovascular disease beginning in
childhood since 1973 [21], the present study examines the
modulating eﬀect of β2-AR Arg16Gly and β3-AR Trp64Arg
polymorphisms on the association between birthweight and2 Journal of Biomedicine and Biotechnology
longitudinal changes of BP from childhood to adulthood in
blackandwhiteasymptomaticyoungeradultsenrolledinthe
Bogalusa Heart Study.
2. Methods
2.1. Study Cohort. In the community of Bogalusa, LA, 9
cross-sectional surveys of children aged 4–17 years between
1973 and 1994 and 10 cross-sectional surveys of young
adults aged 18–48 years between 1987 and 2009, who had
been previously examined as children, were conducted for
cardiovascular risk factors. This panel design of repeated
cross-sectionalexaminationsconductedapproximatelyevery
3 years has resulted in serial observations from childhood to
adulthood. A total of 739 adult subjects (515 whites and 224
blacks; 42.2% males; age range = 21–47 years; mean age =
36.7years)whohadβ-ARgenepolymorphismgenotypedata
formed the study cohort for this report. The study subjects
have been serially examined 4–14 times (at least 2 times
each in childhood and adulthood) for BP over an average
of 26.7 years, with 5793 observations. Birthweight records
of the participants were obtained from the Oﬃce of Health
StatisticsinNewOrleans,Louisiana.Allsubjectsinthisstudy
gave informed consent at each examination, and for those
under 18 years of age, consent of a parent/guardian was
obtained. Study protocols were approved by the Institutional
Review Board of the Tulane University Health Sciences
Center.
2.2. General Examinations. All surveys since 1973 followed
the same protocols, and procedures for the general examina-
tions were described elsewhere [22]. Height and weight were
measured twice to ±0.1cm and to ±0.1kg, respectively.
Body mass index (BMI, weight in kilograms divided by
the square of the height in meters) was used as a measure
of overall adiposity. BP levels were measured on the right
arm of subjects in a relaxed, sitting position by 2 nurses (3
replicates each). The ﬁrst and fourth Korotkoﬀ phases were
used to determine systolic (SBP) and diastolic (DBP) blood
pressures, respectively. Means of replicate readings were used
for analyses. For subjects (n = 57) who were on medications
for hypertension at the time of examination, we adjusted the
recordedBPlevelsbyadding10mmHgtoSBPand5mmHg
to DBP, based on average treatment eﬀects [23, 24].
2.3. Genotyping. Genotyping of β2-AR Arg16Gly and β3-AR
Trp64Arg polymorphisms was performed using the TaqMan
assay(AppliedBiosystems,Inc.,Foster,CA)inthelaboratory
of the Human Genetics Center, University of Texas School
of Public Health, 1200 Hermann Pressler, E447, Houston.
Ampliﬁcation conditions and information on primer and
probesequenceshavebeenpreviouslydescribed[25,26].The
reproducibility of genotyping of the three polymorphisms
was 100% assessed by 64 blind duplicates.
2.4. Statistical Methods. Cubic growth curves of BP mea-
sured repeatedly at multiple time points from childhood to
adulthood were established by race and sex groups using a
random eﬀects model by SAS Proc MIXED. As shown in
Figure 1 using SBP of two white males as an example, the
area under the curve (AUC) was calculated as the integral
of the growth curve parameters during the follow-up period
for each individual [27, 28]. Total AUC (baseline AUC +
incremental AUC) is considered a measure of long-term
levels. Incremental AUC determined by within-individual
variability represents a combination of linear and nonlinear
longitudinal trends and was used as the measure of age-
related trend. Since individuals had diﬀerent follow-up
periods, the AUC values were divided by the number of
follow-up years for further analyses. The AUC measures have
advantages over other longitudinal analysis models in that
they measure both the long-term levels and trends.
Race diﬀerences in distributions of genotypes and allele
frequencies were tested using a contingency chi-square test.
Diﬀerences in mean values of continuous study variables
betweenrace-sexgroupsweretestedbyanalysisofcovariance
models.Therateoffetalgrowthwascalculatedasbirthweight
inkilograms/gestationalageinweeksforeachindividual,and
then multiplied by the mean gestational age of the sample to
make the scale close to the original values. The gestational
age-adjustedbirthweightwasusedinallsubsequentanalyses.
T h ei m p a c to fg e n o t y p ea n db i r t h w e i g h to nB Pw a se x a m -
ined by multiple regression models by race and in the total
sample, adjusting for sex, current age, and race (for the total
sample). In order to examine the impact of BMI adjustment
on the relation between birthweight and BP, two types
of regression analyses were performed, with and without
adjustment for current BMI. In addition to the above covari-
ates, the baseline BP (the ﬁrst measurement in childhood)
was also included in the regression models for the age-
related trend analyses to control for the regression-to-the-
mean bias because the baseline values were closely associated
with the age-related trend measured by incremental AUC.
The diﬀerences in slopes (birthweight-genotype interaction
on BP) were tested using a homogeneity-of-slopes model, a
regression interaction model, among genotype groups. Due
to signiﬁcant diﬀerences in BP levels, birthweight and gene
allele frequencies between blacks and whites, BP measures
(childhood, adulthood, AUC, and age-related trend), and
birthweight were standardized into Z-scores (mean = 0a n d
SD = 1)by racegroupsprior to regression analysesto remove
the inﬂuence of population stratiﬁcation.
3. Results
Table 1 showsthemeanlevelsofstudyvariablesinchildhood,
adulthood, and at birth, and AUC values by race and
sex. The ﬁrst measurement of childhood SBP and DBP
did not signiﬁcantly diﬀer between races or sexes. The
last measurement of adulthood SBP and DBP diﬀered
signiﬁcantly by race (blacks > whites) and by sex (males >
females) except for sex diﬀerence in blacks. Total AUC and
age-related trend of SBP showed signiﬁcant race (blacks >
whites) and sex (males > females) diﬀerences; signiﬁcant
sex diﬀerences (males > females) were noted for total DBP
AUC in both races and a signiﬁcant race diﬀerence (blacks >
whites)infemalesonly.Theage-relatedtrendofDBPshowedJournal of Biomedicine and Biotechnology 3
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Figure 1: Illustration for Calculation of Area under the Curve of Systolic Blood Pressure: The Bogalusa Heart Study.
a signiﬁcant race diﬀerence (blacks > whites) among females
only and a sex diﬀerence (males > females) among whites
only. Blacks had signiﬁcantly lower birthweight than whites,
but males had signiﬁcantly higher birth weight than females
only among whites.
Blacks displayed a lower alleles frequencies of β2-AR
Gly16 (0.507 versus 0.630, P<. 001) and β3-AR Trp64 (0.895
versus 0.925, P = .008) than whites. The genotype distribu-
tions were in accordance with Hardy-Weinberg equilibrium
expectations in blacks and whites (data not shown).
Standardized regression coeﬃcients for β-AR genotypes,
race-adjusted birthweight, and covariates for race-adjusted
BP are presented in two models in Table 2. Since race-
birthweight and race-gene interactions on BP were not
signiﬁcant, the results of the total sample with blacks and
whites combined are displayed. Race was not included in
the models because birthweight and BP were adjusted for
race by standardization prior to the regression analyses.
The associations between race and Z-scores of BP measures
(childhood, adulthood, AUC and age-related trend) were no
longer signiﬁcant (P = .725–.896). In model I with current
BMI included, childhood age and current BMI, but not
birthweight, were associated with the ﬁrst SBP measurement
in childhood. Female sex, older age, higher adulthood BMI,
and lower birthweight were signiﬁcantly associated with
higher values of the last SBP measurement in adulthood,
total SBP AUC, and SBP age-related trend. Birthweight was
signiﬁcantly associated with adulthood DBP levels and age-
related trend; however, the association was weaker than for
SBP. In addition, the ﬁrst BP measurement in childhood
(the baseline value) was also a signiﬁcant predictor of
the age-related trend of both SBP and DBP. In model II
without current BMI included, the eﬀect of birthweight
on SBP was attenuated to some extent for adulthood SBP,
SBP AUC, and the age-related trend, but they were still
signiﬁcant;theregressioncoeﬃcientsforothercovariatesdid
not considerably changed compared with those in model I.
Birthweight was associated with the age-related trend only
for DBP in model II. The main eﬀect of individual β2-AR
and β3-AR polymorphism genotype on SBP and DBP was
not signiﬁcant in both model I and model II without any
interaction terms included.
Figure 2 illustrates the magnitude of the association of
birthweight with SBP age-related trend, measured as stan-
dardized regression coeﬃcients, by the combination of β2-
AR and β3-AR genotypes. The regression coeﬃcients of SBP
age-related trend on birthweight were derived from multiple
regression models using race-adjusted birthweight and BP4 Journal of Biomedicine and Biotechnology
Table 1: Mean Levels and SD of Study Variables by Race and Sex.
Whites Blacks
Males Females Males Females P-value for diﬀerence
(n = 226) (n = 289) (n = 86) (n = 138)
Mean SD Mean SD Mean SD Mean SD Race Sex
Childhood
Age (year) 10.3 2.9 9.7 3.0 10.0 2.9 9.6 2.7 NS <.05w
Systolic BP (mmHg) 100.8 9.4 99.4 9.1 99.8 11.8 99.0 9.6 NS NS
Diastolic BP (mmHg) 61.7 8.2 62.2 8.8 62.4 8.0 61.0 8.6 NS NS
Adulthood
Age (year) 37.6 5.1 36.7 5.5 35.0 5.9 35.9 5.7 <.01m NS
Systolic BP (mmHg) 117.1 10.7 109.5 10.8 122.8 15.2 119.3 17.3 <.01 <.05w
Diastolic BP (mmHg) 78.9 8.0 73.8 7.9 81.2 11.8 78.7 11.5 <.05 <.05
AUC Values (mmHg)
Systolic BP total 113.1 7.2 106.9 5.5 115.0 7.6 110.7 6.8 <.05 <.01
Systolic BP trend 11.8 5.1 7.5 5.3 15.6 6.6 11.8 6.2 <.01 <.01
Diastolic BP total 72.3 5.8 69.7 4.5 72.3 6.2 70.8 5.0 <.01f <.05
Diastolic BP trend 10.8 3.3 8.1 4.0 10.8 3.8 9.7 4.2 <.01f <.01w
At Birth
Gestational age (week) 39.8 1.6 39.6 2.0 39.2 2.3 39.5 1.8 <.05m NS
Birth weight (kg) 3.46 0.5 3.34 0.6 3.09 0.6 3.00 0.6 <.01 <.05w
Birth weight (kg)† 3.44 0.5 3.33 0.5 3.10 0.5 3.00 0.5 <.01 <.05w
BP: blood pressure; AUC: area under the curve.
NS : P>. 05; f : females only; m: males only; w : whites only.
† adjusted for gestational age.
Table 2: Standardized regression coeﬃcients of race-adjusted blood pressure on birth weight, β-adrenergic receptor genotypes, and
covariates.
Systolic BP Diastolic BP
First Last AUC Trend First Last AUC Trend
Model I
Childhood BP — — — −0.43∗∗ —— — −0.44∗∗
Female sex −0.05 −0.24∗∗ −0.37∗∗ −0.38∗∗ 0.02 −0.22∗∗ −0.19∗∗ −0.28∗∗
Age 0.22∗∗ 0.19∗∗ 0.17∗∗ −0.20∗∗ 0.28∗∗ 0.25∗∗ 0.34∗∗ −0.02
BMI 0.16∗∗ 0.36∗∗ 0.26∗∗ 0.23∗∗ 0.06 0.34∗∗ 0.21∗∗ 0.26∗∗
Birth weight† −0.004 −0.11∗∗ −0.11∗∗ −0.10∗∗ 0.04 −0.07∗ −0.07∗ −0.08∗
β2-AR genotype −0.04 −0.03 −0.04 0.01 −0.05 −0.02 −0.03 −0.01
β3-AR genotype −0.04 −0.01 −0.02 0.02 −0.05 −0.01 −0.05 −0.01
Model II
Childhood BP — — — −0.40∗∗ —— — −0.42∗∗
Female sex −0.05 −0.25∗∗ −0.38∗∗ −0.39∗∗ 0.01 −0.24∗∗ −0.20∗∗ −0.29∗∗
Age 0.23∗∗ 0.22∗∗ 0.19∗∗ −0.19∗∗ 0.28∗∗ 0.28∗∗ 0.36∗∗ −0.01
Birth weight† −0.004 −0.09∗∗ −0.10∗∗ −0.09∗∗ 0.04 −0.05 −0.06 −0.07∗
β2-AR genotype −0.05 −0.05 −0.05 −0.02 −0.05 −0.04 −0.04 −0.02
β3-AR genotype −0.04 −0.01 −0.02 0.02 −0.05 −0.01 −0.05 −0.01
First: the ﬁrst measurement in childhood; last: the last measurement in adulthood; BP: blood pressure;
AUC: area under the curve; BMI: body mass index.
β2-AR genotype = β2-adrenergic receptor Arg16Gly (coding: 0, 1, and 2 of Arg alleles).
β3-AR genotype = β3- adrenergic receptor Trp64Arg (coding: 0 = Arg/Arg and Trp/Arg, 1 = Trp/Trp).
† adjusted for gestational age.
∗P<. 05; ∗∗P<. 01.Journal of Biomedicine and Biotechnology 5
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Figure 2: Relationship between Age-related Trend of Systolic Blood
Pressure and Birth Weight by β2-AR Arg16Gly and β3-AR Trp64Arg
Genotypes: The Bogalusa Heart Study Arg/x stands for Arg/Trp and
Arg/Arg genotypes combined.
in terms of race-speciﬁc Z-scores, adjusting for the ﬁrst SBP
measurement in childhood, adulthood age, and sex, without
any interaction terms. Because the regression coeﬃcients
were all negative, standardized regression coeﬃcients ×(−1)
were presented in Figure 2 for convenience. The regression
coeﬃcients showed opposite trends with increasing number
oftheβ2-ARArg16allelesinthetwoβ3-ARgenotypegroups.
The birthweight eﬀe c to nS B Pt r e n d( β =− 0.12, P = .014,
n = 224) was the greatest among individuals who had β3-
AR Trp/Trp and β2-AR Gly/Gly genotypes; having β3-AR
Arg/x and β2-AR Arg/Arg genotypes was associated with the
highest eﬀect of β =− 0.28 (P = .257, n = 21). The overall 3-
way interaction (birthweight-β2-AR-β3-AR) was signiﬁcant
(P = .042),suggestingthattherelationshipbetweenSBPage-
related trend and birthweight depends on the combination
of β2-AR and β3-AR genotypes. Further, the interaction of
individual polymorphisms with birthweight on SBP trend
was not signiﬁcant in the 2-way interaction models without
a 3-way interaction term included (data not shown).
Figure 3 presents the strength of the association of
birthweight with SBP age-related trend by the combination
of β2-AR and β3-AR genotypes in blacks and whites using
the race-speciﬁc Z-scores of birthweight and SBP age-related
trend. The pattern of the standardized regression coeﬃcients
of SBP age-related trend on birthweight by β2-AR and β3-
AR genotypes was similar in the two race groups; the four-
way interaction (race-birthweight-β2-AR-β3-AR) was not
signiﬁcant (P = .523).
ForDBPage-relatedtrend,asimilarpatternofregression
coeﬃcients to SBP was observed with respect to β2-AR and
β3-AR genotypes; the birthweight-β2-AR-β3-AR interaction
on DBP age-related trend was signiﬁcant (P = .039) in the
total sample. Blacks and whites did not show any diﬀerence
in the birthweight-genotype interaction on DBP age-related
trend (P = .682).
4. Discussion
Many studies have shown that low birthweight is inversely
associated with high BP and hypertension in later life [1–4]
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Figure 3: Relationship between Age-related Trend of Systolic Blood
Pressure and Birth Weight by β2-AR Arg16Gly and β3-AR Trp64Arg
Genotypes in Blacks and Whites: The Bogalusa Heart Study Arg/x
stands for Arg/Trp and Arg/Arg genotypes combined.
although there exist criticisms and concerns [3, 8–12]. Sys-
tematicreviewsoftheliteraturesuggestaninverselinearrela-
tionship between SBP and birthweight of ∼1-2mmHg/kg
[29]. However, most previous studies in this regard focused
onBPlevels;limitedinformationisavailableontheinﬂuence
of birthweight on longitudinal changes of BP. The present
community-based study demonstrates an adverse eﬀect of
low birthweight on BP in terms of adulthood BP, the long-
term levels, and increasing trend from childhood to young
adulthood, especially for SBP. However, the birthweight-BP
association was not noted in childhood in the study cohort.
The hypothesis of the fetal origins of hypertension
proposed several possible mechanisms linking reduced fetal
growth and elevated BP in later life, such as persisting
changes in vascular structure, including loss of elasticity
in vessel walls, eﬀects of glucocorticoid hormones, and
abnormalities of nephrogenesis [1, 2]. Furthermore, low
birthweight may be associated with elevated sympathetic
nervous system activity in adulthood, as measured by heart
rate, preejection period, and respiratory sinus arrhythmia
[30, 31]. These ﬁndings suggest that increased sympathetic
nervous system activity established in utero may be one of
the mechanisms linking low birthweight with high BP in
adults. Although genetic factors have been found to play a
role in the birthweight-BP relationship in family and twin
studies [31–33], limited information on speciﬁc genes has
become available. We noted in the current study that the
association between birthweight and age-related trend of BP
was dependent on the combination of by β2-AR and β3-AR
genotypes, suggesting that β-AR gene variants play a role, in
an interactive manner, in BP regulation of adults who have a
low birthweight, an indicator of fetal growth restriction.
It is well established that both BP regulation and
birthweight are genetically determined [34, 35]. Candidate
genes and chromosomal regions have been identiﬁed for
birthweight [36, 37]. β-ARs are an important component
of the sympathetic nervous system [13, 14]. Polymorphisms
of the β-AR genes have been found to be associated with6 Journal of Biomedicine and Biotechnology
multiplecardiovascularriskfactors,includinghemodynamic
status and obesity measures. Previous studies have shown
that β2-AR Gly16 and β3-AR Arg64 alleles were associated
with BP elevation or hypertension, although the ﬁndings
on β2-AR Gly16 allele have been questioned [16, 38]. In
the present study, we did not ﬁnd a signiﬁcant association
of β2-AR Arg16Gly and β3-AR Trp64Arg polymorphisms,
individually, with BP in terms of childhood, adulthood, and
long-term BP levels, and the age-related trend. However,
the two genes were found to interactively inﬂuence the
relationship of birthweight to longitudinal changes of BP.
Individuals who were born a lower weight and have β2-AR
Arg/Arg and β3-AR Arg allele or β2-AR Gly/Gly and β3-
AR Trp/Trp genotypes are prone to have a faster increase
in BP after birth compared with those having a normal
birthweight and other β2-AR and β3-AR genotypes. Data on
3-way interaction (birthweight-β2-AR-β3-AR) on BP, which
is a complex interplay, have not been previously reported.
Further studies with multiple polymorphisms of the two
genes are needed to conﬁrm the ﬁndings in this study with
respect to the possible important loci which are in linkage
disequilibrium with β2-AR Arg16Gly and β3-AR Trp64Arg
polymorphisms.
In the United States, blacks have a greater prevalence of
bothlowbirthweightandhypertensionthanwhites;however,
it is not yet established that excess risk of hypertension
in blacks is programmed in utero [39]. In some studies
black children showed a weaker birthweight-BP association
than white children, or none at all [40–43]. A weaker
birthweight-BP association in blacks was also observed in
our previous study in a separate cohort [44]. However, the
modulating eﬀect of β2-AR and β3-AR genes, individually
or in combination, on the association between birthweight
and longitudinal changes of BP did not diﬀer between
blacks and whites in the present study. In addition to race
diﬀerences in brithweight and BP, β2-AR and β3-AR genes
allele frequencies also diﬀered signiﬁcantly between blacks
and whites in this study cohort. Strong correlations among
these study variables would lead to a serious bias resulted
from population stratiﬁcation when blacks and whites were
combined for analysis. For this reason, BP and birthweight
were standardized by race groups, and then race-speciﬁc Z-
scores were used in association and interaction analyses in
the present study.
It is well known that size at birth is strongly related to
fetalgenotype,uterineenvironment,andanumberofmater-
nal factors including parity, length of gestation, mother’s
adult size, mother’s own birthweight, as well as mother’s
genotype [34, 45]. Because of the correlation of maternal
and fetal genotypes of multiple relevant genes, maternal
genotypes are expected to have a confounding eﬀect on the
birthweight-BP relationship as well as its genetic modulation
by β2-AR and β3-AR gene polymorphisms noted in this
study. However, mother’s genotype data are not available
in our cohort. Another limitation of this community-based
studyisthatonlyonesinglepolymorphismwastypedineach
of the two genes under study.
In summary,we found in the current study that low birth
weight was associated with a greater increase in BP levels
from childhood to adulthood. This relationship was mod-
ulated by the combination of β2-AR and β3-AR genotypes.
These ﬁndings support the emerging concept of intrauterine
programming and its pathophysiologic consequences after
birth and underscore the role of genetic factors in the fetal
origins of hypertension later in life. Since no data in this
regard are available for comparison, our ﬁndings need to be
replicated in other populations.
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